Chronic hepatitis B virus (HBV) can progress to cirrhosis and hepatocellular carcinoma (HCC). A study published in The Journal of Molecular Diagnostics describes a new HBV assay that offers advantages over currently used ...
Apr 12, 2018
0
7
Some 300 million people worldwide are living with the deadly hepatitis B virus (HBV), but only one in 20 received adequate treatment, researchers reported Tuesday.
Mar 27, 2018
0
421
(HealthDay)—For patients with chronic hepatitis B virus (HBV), body mass index (BMI) is significantly associated with increased risk of hepatocellular carcinoma (HCC), with the risk more pronounced for women than men, according ...
Mar 26, 2018
0
2
In a surprising discovery, researchers from the Singapore Immunology Network (SIgN), A*STAR, have found that the liver is the main site of hepatitis B (HBV) replication—not only because it contains material that helps the ...
Feb 13, 2018
0
5
Reducing chronic hepatitis B infections by screening at-risk adults, increasing hepatitis B vaccination rates, and linking infected persons to care is a public health priority, the American College of Physicians (ACP) and ...
Nov 20, 2017
0
0
(HealthDay)—Elevated levels of hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) are associated with increased risks of liver cancer, according to a study published online Oct. 24 in the Journal of Gastroenterology ...
Nov 1, 2017
0
0
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.
Oct 20, 2017
0
0
Arrowhead Pharmaceuticals today announced results from studies of ARC-520, a prior-generation RNAi therapeutic candidate against chronic hepatitis B virus (HBV) infection, in a Phase 2 clinical study in HBV patients and a ...
Sep 27, 2017
0
3
(HealthDay)—For hepatitis B virus (HBV) carriers, hepatitis B virus core-related antigen (HBcrAg) levels are associated with progression to cirrhosis, according to a study published online Sept. 15 in the Journal of Gastroenterology ...
Sep 21, 2017
0
0
(HealthDay)—Hepatitis B virus (HBV) reactivation (HBV-R) is a safety concern for patients with HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral agents (DAAs), according to a study published ...
Apr 25, 2017
0
0
